Compare ATOS & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOS | DHX |
|---|---|---|
| Founded | 2009 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 79.7M |
| IPO Year | 2012 | 2007 |
| Metric | ATOS | DHX |
|---|---|---|
| Price | $4.24 | $2.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $31.67 | $6.25 |
| AVG Volume (30 Days) | 256.9K | ★ 813.5K |
| Earning Date | 03-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $127,826,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.76 | $1.21 |
| 52 Week High | $19.35 | $3.34 |
| Indicator | ATOS | DHX |
|---|---|---|
| Relative Strength Index (RSI) | 65.41 | 62.10 |
| Support Level | $3.76 | $2.26 |
| Resistance Level | $5.54 | $2.96 |
| Average True Range (ATR) | 0.48 | 0.23 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 49.34 | 52.81 |
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.